| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0076-6879(96)72021-9 |
| P698 | PubMed publication ID | 8791775 |
| P2093 | author name string | D D Breimer | |
| K Groen | |||
| P2860 | cites work | Characterisation of theophylline metabolism in human liver microsomes | Q34416806 |
| Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach | Q34418061 | ||
| Prediction of xenobiotic metabolism by non-invasive methods | Q37829237 | ||
| A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans | Q37946157 | ||
| Therapeutic Drug Monitoring in Saliva | Q38243033 | ||
| Disposition of hexobarbital: 15 years of an intriguing model substrate | Q39567059 | ||
| Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene Treatment | Q39710232 | ||
| Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation. | Q40467542 | ||
| Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. | Q41142887 | ||
| Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man | Q41905249 | ||
| Differential effects of enzyme induction on antipyrine metabolite formation | Q42021525 | ||
| Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers | Q42285318 | ||
| Assessment of antipyrine kinetics by measurement in saliva | Q43255360 | ||
| Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine. | Q52869969 | ||
| Age-associated stereoselective alterations in hexobarbital metabolism | Q68309596 | ||
| Simultaneous quantitation of d- and l-hexobarbital in rat blood by high-performance liquid chromatography | Q69425006 | ||
| Theophylline: a remarkable window to the hepatic microsomal oxidases | Q70335270 | ||
| Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time | Q70336540 | ||
| The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women | Q70490332 | ||
| Interindividual variations in drug disposition. Clinical implications and methods of investigation | Q71064667 | ||
| Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism | Q71388580 | ||
| Improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma using solid-phase extraction | Q93616783 | ||
| P304 | page(s) | 169-177 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs | |
| P478 | volume | 272 |
| Q41916988 | An in vivo assay for elucidating the importance of cytochromes P450 for the ability of a wild mammalian herbivore (Neotoma lepida) to consume toxic plants | cites work | P2860 |
Search more.